...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: OTC Trading questions

,,yep,,CM,,,,,Im in the same predicament,,,in this play along with the sister company for too long and with too much hard earned money from past years. Our mistake for following the forward looking statements from a team of do nots ,,or can nots,,or should nots,,,,lead by a CEO who clearly exhibits the beginning of dementia,,ie;,,lack of concentration,,,,apathy towards advancing work,,,,and loss of ability to do every day tasks in running a company. Anything over a buck is fine with me..it would be a break even,,,,and Ill chaulk the loss of time and money up to being out smarted by an event promeoter!!

Share
New Message
Please login to post a reply